Status | Study |
Completed |
Study Name: β-RELIEVED - REsponse in Acute fLare and In prEVEntion of episoDes of Re-flare in Gout - Extension 3 (E3) Condition: Acute Gouty Arthritis Flares Date: 2011-08-16 Interventions: Drug: ACZ885 canakinumab 150 mg s.c., given on demand upon new flares |
Completed |
Study Name: Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective Condition: Gouty Arthritis Date: 2011-05-24 Interventions: Drug: Canakinumab, ACZ885 Cana |
Completed |
Study Name: Safety and Efficacy of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients Condition: Acute Gouty Arthritis Date: 2011-05-16 Interventions: Drug: Canakinumab pre-filled syringe |
Withdrawn |
Study Name: Apremilast Therapy for Acute Gouty Arthritis Condition: Acute Gout Date: 2009-10-09 Interventions: Drug: apremilast apremilast 20 |
Completed |
Study Name: Long Term Study of Canakinumab (ACZ885) in Patients With Gout Condition: Gout Date: 2009-06-23 Interventions: Drug: Canakinumab |
Completed |
Study Name: Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy Condition: Gout Date: 2009-01-08 Interventions: Drug: Canakinumab 25 mg 25 mg |
Completed |
Study Name: Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients Condition: Chronic Gout Refractory to Conventional Therapy Date: 2008-05-06 Interventions: Drug: pegloticase 8 mg i.v. pegloticase 8 mg i.v. every 2 weeks for 24 weeks |
Completed |
Study Name: Efficacy and Safety of a Single Dose of Canakinumab (ACZ885) in Hospitalized Patients With Acute Gout Condition: Arthritis, Gouty Date: 2008-04-18 Interventions: Biological: canakinumab 10 mg/ |
Completed |
Study Name: Celebrex In Acute Gouty Arthritis Study Condition: Arthritis, Gouty Date: 2007-10-24 Interventions: Drug: Indomethacin indomethaci |
Completed |
Study Name: Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout Condition: Acute Gouty Arthritis Date: 2005-09-09 Interventions: Drug: Lumiracoxib |